Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

DNA Damaging Agents Cause a Sub-Cellular Re-Localisation of Nucleophosmin in an npm1 Mutated Acute Myeloid Leukemia (AML) Cell Line and in Primary AML Cells Carrying an npm1 Mutation

Graham D. Bailey, PhD, Asma Akhtar, BSc, Nigel H. Russell, Claire Seedhouse, PhD

Blood (2017) 130 (Supplement 1): 1251.

https://doi.org/10.1182/blood.V130.Suppl_1.1251.1251

Published: 2017

Journal Articles

Effectiveness of Transcriptional CDK Inhibitors in Targeting Non-Proliferating CD34+CD38- AML Cells,

Monica Pallis, PhD, Francis Burrows, PhD, Abigail Whittall, B Med Sci, Claire Seedhouse, PhD, Nicholas Boddy, B Med Sci, Nigel H. Russell, MD

Blood (2011) 118 (21): 3482.

https://doi.org/10.1182/blood.V118.21.3482.3482

Published: 2011

Journal Articles

An Immortalised Leukaemia Cell Line Models the Quiescence of Leukaemic Stem Cells and Shows Impaired Double Strand Break Repair Following Daunorubicin Treatment

Claire Seedhouse, Abigail Whittall, Karuna Tandon, Nigel H. Russell, MD, Monica Pallis, PhD

Blood (2010) 116 (21): 3989.

https://doi.org/10.1182/blood.V116.21.3989.3989

Published: 2010

Journal Articles

A Polymorphism In the 3'UTR Region of ABCB1 Is Associated with Increased Allele Activity with Corresponding Increases In P-Glycoprotein Expression and Function

Nada Bajuaifer, Martin Grundy, BSc, Robert Hills, MA, MSc, DPhil, Nigel H. Russell, MD, Monica Pallis, PhD, Claire Seedhouse

Blood (2010) 116 (21): 3990.

https://doi.org/10.1182/blood.V116.21.3990.3990

Published: 2010

Journal Articles

RHPS4, An Anti-Telomere Agent, Specifically Targets the Subgroup of AML Cells with Loss or Gain of Parts of Chromosomes.

Monica Pallis, PhD, Simone Clarke, Martin Grundy, BSc, Jaineeta Richardson, Dotun Ojo, Susan Anderson, Nigel H. Russell, MD, Claire Seedhouse

Blood (2010) 116 (21): 1195.

https://doi.org/10.1182/blood.V116.21.1195.1195

Published: 2010

Journal Articles

Impaired S Phase Arrest in AML Cells with a FLT3-ITD Treated with Clofarabine Allows Prolonged Drug exposure to Reverse the Chemoresistant Phenotype.

Claire Seedhouse, PhD, Martin Grundy, BSc, Shili Shang, MD, MSc, John Ronan, CSci, FIBMS, Heather Pimblett, Nigel H. Russell, MD, Monica Pallis, PhD

Blood (2009) 114 (22): 1000.

https://doi.org/10.1182/blood.V114.22.1000.1000

Published: 2009

Journal Articles

The Telomerase Inhibitor RHPS4 Induces Telomere Shortening, DNA-Damage and Cell Death in AML Cells and Chemosensitises Cells to Daunorubicin.

Monica Pallis, PhD, Dotun Ojo, Jaineeta Richardson, MSc, John Ronan, CSci, FIBMS, Malcolm Stevens, PhD, FRS, Nigel H. Russell, MD, Claire Seedhouse, PhD

Blood (2009) 114 (22): 2760.

https://doi.org/10.1182/blood.V114.22.2760.2760

Published: 2009

Journal Articles

Regulation of ABCB1 (p-glycoprotein) by the FOXO1 Transcription Factor in Acute Myeloid Leukemia.

Claire Seedhouse, PhD, Sophie Ahluwalia, BSc, Ken I Mills, Ph.D., FRCPath, Martin Grundy, BSc, Shili Shang, MD, MSc, Alan K. Burnett, MD, FRCP, Nigel H. Russell, MD, Monica Pallis, PhD

Blood (2009) 114 (22): 589.

https://doi.org/10.1182/blood.V114.22.589.589

Published: 2009

Journal Articles

Genetic Polymorphisms of DNA-Repair- and Detoxification Enzymes in Therapy-Related AML and MDS.

Stephanie Fischer, Claire Seedhouse, PhD, Thomas Schulz, PhD, Ulrich Germing, PhD, MD, Lorenz H. Truemper, PhD, MD, Detlef Haase, PhD, MD

Blood (2007) 110 (11): 4223.

https://doi.org/10.1182/blood.V110.11.4223.4223

Published: 2007

Journal Articles

P-Glycoprotein Is Downregulated in KG1a Primitive Leukaemia Cells by LDL Cholesterol Deprivation and by HMG-CoA Reductase Inhibitors.

Laura Connelly-Smith, MBBCh, Joanne Pattinson, Martin Grundy, Shili Shang, Claire Seedhouse, PhD, Nigel Russell, MBChB, Monica Pallis, PhD

Blood (2007) 110 (11): 4192.

https://doi.org/10.1182/blood.V110.11.4192.4192

Published: 2007

Journal Articles

Polymorphisms in Human Homeobox HLX1 and DNA Repair RAD51 Genes Increase the Risk of Therapy-Related Acute Myeloid Leukemia.

Mays Jawad, PhD, Claire Seedhouse, PhD, Nigel H. Russell, MD, Mark Plumb, PhD

Blood (2006) 108 (11): 1171.

https://doi.org/10.1182/blood.V108.11.1171.1171

Published: 2006

Journal Articles

A Role for DNA Double Strand Breaks in the Sensitivity of AML Cells to Clofarabine: Enhanced In Vitro Sensitivity in Primary AML Cells with FLT3 Mutations.

Monica Pallis, PhD, Martin Grundy, BSc, Claire Seedhouse, PhD, Heather Pimblett, B Med Sci, Nigel Russell, MD

Blood (2006) 108 (11): 2582.

https://doi.org/10.1182/blood.V108.11.2582.2582

Published: 2006

Journal Articles

The genotype distribution of the XRCC1 gene indicates a role for base excision repair in the development of therapy-related acute myeloblastic leukemia

Claire Seedhouse, Rowena Bainton, Michael Lewis, Alexander Harding, Nigel Russell, Emma Das-Gupta

Blood (2002) 100 (10): 3761–3766.

https://doi.org/10.1182/blood-2002-04-1152

Published: 2002

NARROW

DNA Damaging Agents Cause a Sub-Cellular Re-Localisation of Nucleophosmin in an npm1 Mutated Acute Myeloid Leukemia (AML) Cell Line and in Primary AML Cells Carrying an npm1 Mutation

Effectiveness of Transcriptional CDK Inhibitors in Targeting Non-Proliferating CD34+CD38- AML Cells,

An Immortalised Leukaemia Cell Line Models the Quiescence of Leukaemic Stem Cells and Shows Impaired Double Strand Break Repair Following Daunorubicin Treatment

A Polymorphism In the 3'UTR Region of ABCB1 Is Associated with Increased Allele Activity with Corresponding Increases In P-Glycoprotein Expression and Function

RHPS4, An Anti-Telomere Agent, Specifically Targets the Subgroup of AML Cells with Loss or Gain of Parts of Chromosomes.

Impaired S Phase Arrest in AML Cells with a FLT3-ITD Treated with Clofarabine Allows Prolonged Drug exposure to Reverse the Chemoresistant Phenotype.

The Telomerase Inhibitor RHPS4 Induces Telomere Shortening, DNA-Damage and Cell Death in AML Cells and Chemosensitises Cells to Daunorubicin.

Regulation of ABCB1 (p-glycoprotein) by the FOXO1 Transcription Factor in Acute Myeloid Leukemia.

Genetic Polymorphisms of DNA-Repair- and Detoxification Enzymes in Therapy-Related AML and MDS.

P-Glycoprotein Is Downregulated in KG1a Primitive Leukaemia Cells by LDL Cholesterol Deprivation and by HMG-CoA Reductase Inhibitors.

Polymorphisms in Human Homeobox HLX1 and DNA Repair RAD51 Genes Increase the Risk of Therapy-Related Acute Myeloid Leukemia.

A Role for DNA Double Strand Breaks in the Sensitivity of AML Cells to Clofarabine: Enhanced In Vitro Sensitivity in Primary AML Cells with FLT3 Mutations.

The genotype distribution of the XRCC1 gene indicates a role for base excision repair in the development of therapy-related acute myeloblastic leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only